Whittington, M. D., McQueen, R. B., Ollendorf, D. A., Kumar, V. M., Chapman, R. H., Tice, J. A., . . . Campbell, J. D. (2018). Long-term Survival and Value of Chimeric Antigen Receptor T-Cell Therapy for Pediatric Patients With Relapsed or Refractory Leukemia. JAMA Pediatr.
Chicago-tyylinen lähdeviittausWhittington, Melanie D., R. Brett McQueen, Daniel A. Ollendorf, Varun M. Kumar, Richard H. Chapman, Jeffrey A. Tice, Steven D. Pearson, ja Jonathan D. Campbell. "Long-term Survival and Value of Chimeric Antigen Receptor T-Cell Therapy for Pediatric Patients With Relapsed or Refractory Leukemia." JAMA Pediatr 2018.
MLA-viiteWhittington, Melanie D., et al. "Long-term Survival and Value of Chimeric Antigen Receptor T-Cell Therapy for Pediatric Patients With Relapsed or Refractory Leukemia." JAMA Pediatr 2018.